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Abstract
The introduction of nationwide pneumococcal vaccination may lead to serotype replacement and the emergence of new
variants that have expanded their genetic repertoire through recombination. To monitor alterations in the pneumococcal
population structure, we have developed and utilized Capsular Sequence Typing (CST) in addition to Multiple-Locus
Variable number tandem repeat Analysis (MLVA). To assess the serotype of each isolate CST was used. Based on the
determination of the partial sequence of the capsular wzh gene, this method assigns a capsular type of an isolate within a
single PCR reaction using multiple primersets. The genetic background of pneumococcal isolates was assessed by MLVA.
MLVA and CST were used to create a snapshot of the Dutch pneumococcal population causing invasive disease before the
introduction of the 7-valent pneumococcal conjugate vaccine in the Netherlands in 2006. A total of 1154 clinical isolates
collected and serotyped by the Netherlands Reference Laboratory for Bacterial Meningitis were included in the snapshot.
The CST was successful in discriminating most serotypes present in our collection. MLVA demonstrated that isolates
belonging to some serotypes had a relatively high genetic diversity whilst other serotypes had a very homogeneous genetic
background. MLVA and CST appear to be valuable tools to determine the population structure of pneumococcal isolates
and are useful in monitoring the effects of pneumococcal vaccination.
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Introduction
Streptococcus pneumoniae is a major human pathogen causing
considerable morbidity and mortality throughout the world. The
pathogen carries a large number of virulence factors, but its
polysaccharide capsule is still considered the most important
virulence factor [1,2]. The capsule provides resistance to
phagocytosis and is therefore important for the survival of the
bacteria at the infection site. Reactivity of the capsular
polysaccharide with specific antisera is the basis of the classical
serotyping technique. Currently, over 90 pneumococcal serotypes
are recognized and approximately a quarter of these serotypes are
responsible for the majority of cases of invasive pneumococcal
disease [3,4,5,6].
In the Netherlands, the 7-valent vaccine PrevenarH was
introduced in 2006 in a 2–3–4 months vaccination scheme plus a
booster at 11 months of age. The 7 serotypes in the vaccine
account for approximately 60% of the serotypes responsible for
invasive pneumococcal disease in the Netherlands [7]. Since
vaccination against the pneumococcus is based on capsular
polysaccharides, immunization will put selective pressure on the
pneumococcal population. Important vaccine effects following
immunization could be serotype replacement and capsule switch.
Serotype replacement, the replacement of vaccine types by non-
vaccine types, is already seen in the U.S.A., where after the
introduction of the vaccine the incidence of invasive disease in
children younger than 5 due to vaccine types declined. In the
USA the overall incidence of invasive pneumococcal disease
(IPD) decreased from 24.4 to 13.8 cases per 100,000 individuals.
Among children aged ,5 years, the IPD rate decreased from
98.7 cases per 100,000 individuals in 1998–1999 to 23.6 cases
per 100,000 individuals in 2005. However, serotype replacement
is occurring, predominantly by non-vaccine serotype 19A. IPD
cases of serotype 19A increased about 3 fold to about 9 cases per
100,000 individuals [8,9,10]. Capsule switch is the ability to
transfer capsule genes, by which the bacteria will change its
serotype but will keep its genetic background [11]. In the U.S.A.
capsule switch was already seen 3 years after the introduction of
the 7-valent vaccine. The Active Bacterial Core (ABC)
surveillance program of the CDC revealed an isolate with an
MLST type associated with serotype 4, which was serotyped as
19A. MLST data as well as sequence of crossover regions and
capsular loci of putative recombinants, recipient and donor
revealed the probable capsular switch [12]. Changes in genotype
and serotype may have considerable consequences for future
vaccination strategies. To monitor alterations in the pneumo-
coccal population, both serotyping and genotyping methods are
required.
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20390The gold standard for serotyping is the Quellung or Neufeld test
[13,14]. This method is time-consuming and the type, group and
factor sera are expensive because they should be kept in-house for
the identification of all serotypes. Some novel molecular
‘serotyping’ methods are described that are rapid and cost-
effective. Brito et al. introduced a multiplex PCR scheme by which
via multiple PCRs 9 serotypes could be identified [15]. Another
serotype specific PCR for 51 serotypes was described by Kong et al.
[16] and was later extended to 90 serotypes [17]. Furthermore, a
widely used conventional assay that is continually updated uses a
sequential series of multiplex PCR reactions for 40 serotypes or
related sets of serotypes (www.cdc.gov/ncidod/biotech/strep/pcr.
htm) [18,19,20]. In these methods several PCRs should be
performed to assess the serotype.
Using both Capsular Sequence Typing (CST) and MLVA
(companion paper, Elberse and Nunes et al.) we may be able to
monitor changes in the pneumococcal population. The CST is a
newly developed molecular method to genotype the capsular locus
in order to assess the serotype. The primers used in the CST are
based on the publicly available sequences of the capsular genes of
the 90 known pneumococcal serotypes [21]. In this report we used
the CST and MLVA to create a snapshot of the composition of the
pneumococcal population causing invasive diseases in the Nether-
lands before the introduction of the 7-valent pneumococcal
conjugate vaccine. The current snapshot will enable comparison
with the post-vaccination population and may provide valuable
insights on vaccine induced changes such as capsule switch and
serotype replacement.
Results
Capsular Sequence Typing compared with classical
serotyping
Thepneumococcalpopulationused forthisstudywascollectedin
thepre-vaccinationerain2004–2005 and was representative forthe
total Dutch pneumococcal population causing invasive disease.
Isolates belonging to serotype 14 and 7F were isolated most often,
among other prevalent serotypes, such as serotypes 1, 4, and 9V
(Table 1). All isolates were isolated from patients with invasive
pneumococcal disease. Eleven percent of the isolates (n=120) were
recovered from cerebrospinal fluid (CSF) and the rest of the isolates
from blood (n=1034). In children aged ,5 years 35% (n=35) were
isolated from CSF (Table 2). Serotype distribution within these
children was slightly different compared with the serotype
distribution in patients $5 years of age. Predominant serotypes
among the children were serotypes 14, 7F, and 6B (Table 3).
In general CST and serotyping were in close agreement
(Table 1). Among the 1154 isolates there were 42 distinct serotypes
and 64 different capsular sequence types (CTs). For 25 (60%) of
the serotypes only a single wzh sequence was found, representing
482 (42%) of all isolates. For the remaining of serotypes 2 or more
wzh sequences per serotype were found. In most cases the variant
wzh sequences within a particular serotype were closely related and
only differed in a few base pairs. However, there were exceptions
where the variant sequences differed in many residues from the
other variants. This was the case for CT06B-02, CT18C-02 and
CT23F-04, which differed 27, 14 and 31 nucleotides from the
most frequently occurring variant, respectively. This resulted in
10, 2 and 10 non-silent amino acid changes, respectively. BLAST
analysis revealed that no perfect match could be found for the
CT18C-02 and CT23F-04 sequence with any of the published wzh
sequences. Although there was close agreement between serotyp-
ing and CST, there were 9 instances comprising 18 isolates (1.6%)
where there was a discrepancy between the phenotypic and
genotypic assignment. In 2 instances isolates were autoagglutinable
in the serotyping and this may resulted in incorrect serotype
assignment. Apparently there is not enough specificity within the
wzh sequences to distinguish serotypes 18B from 18C, 40 from 24F
and 38 from 25F. Analysis of the wzh sequences published by
Bentley et al. [21] corroborates this finding. There was a single
isolate, serotyped as 17F, that carried the same wzh sequence as a
15C isolate and was therefore assigned CT15C-01. Despite
repeated analysis in serotyping and CST this discrepancy
remained. The wzh sequences of CT15C-01 and CT17F-01 only
differed in a single base pair and the serotype assignment of these
isolates remains uncertain. A single isolate serotyped as 15B
carried a wzh sequence that differed in 64 positions from CT15B-
01. BLAST analysis revealed a perfect match with the serotype
15F wzh sequence reported by Bentley et al. [21]. We therefore
assigned CT15F-01 to this isolate. The discrepancy between
serotyping and CST of a single isolate with serotype 40 and
CT24F-01 remained after repeated analysis. Remarkably the
sequence of the segment of the wzh gene of the serotype 24F and
serotype 40 isolates differed from that of the 24F and 40 sequences
published by Bentley et al. [21] in 33 and 80 residues, respectively.
Capsular Sequence Typing of serogroup 6 isolates
The 74 serogroup 6 isolates were shown to contain 6 distinct
CTs within the serogroup. Analysis of the 31 serotype 6A isolates
yielded 4 different sequences in the targeted part of the wzh gene
and 7 of these isolates had the same wzh sequence as a subset of the
6B isolates assigned CT06B-01. The 37 serotype 6B isolates
yielded 3 distinct wzh sequences and one of these sequences
appeared to be identical to those found in some of the 6A isolates
(CT06A-03). There were 2 serotype 6B isolates that carried a wzh
sequence which differed in 27 positions from CT06B-01 in the 506
base pair sequence used for CST. BLAST analysis of this wzh
sequence against GenBank revealed a perfect match with 4
serotype 6B sequences confirming the correct assignment of CST.
Based on the publicly available sequence we designed and used a
6C specific PCR to distinguish serotype 6C from serotype 6A [22].
Of the 74 isolates 6 (8%) yielded PCR products and were assigned
serotype 6C. These isolates carried a wzh gene sequence that
differed from that of all other serotype 6A and 6B isolates and was
assigned CT06C-01. Remarkably, all 6C isolates were obtained
from patients aged between 55 and 75 years of age. The CT06C-
01 sequence only differed in a single base pair from CT06B-01
and 2 or 3 base pairs from the CT06A-variants. In contrast, the
sequence of CT06B-02 was different in 28 base pairs from
CT06C-01. We also used the serotype 6C specific PCR on isolates
serotyped as 6B to distinguish serotype 6D, however, no PCR
product was obtained in these isolates.
Multiple-Locus Variable number tandem repeat Analysis
MLVA of the collection of 1154 pneumococcal isolates showed
that the number of alleles and the degree of the variation in the
number of repeats differed considerably among the BOX loci.
Figure 1 shows the frequency of the alleles (number of repeats) for
each BOX locus and the diversity indices (DI) per locus. BOX_04
was the locus with the highest degree of variation in the number of
repeats (DI=84%) while the BOX_11 locus carried either 1 or 2
repeats in the isolates resulting in a low DI of 46%. Overall the
MLVA had a diversity index of 98%. The number of repeats
varied between BOX loci, ranging from 0 to 17 for BOX_04 and
from 1 to 2 for BOX_11. In 272 isolates (24%) one or more of the
BOX loci could not be amplified even after repeated PCR. If
BOX loci could not be amplified they were assigned allele number
99. Remarkably, BOX_06 could not be amplified in 128 (89%) of
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CST Freq
1 Serotype Freq
2 Mut.Major
3 ds
4 dn
5 Mut.Bentley
6 Discrepancies and other remarks
CT01-01 82 1 82 - -
CT03-01 47 3 47 - 1
CT03-02 2 3 2 1 1 -
CT03-03 11 3 11 1 1 2
CT03-04 1 3 1 1 1 2
CT04-01 86 4 86 - -
CT05-01 8 5 8 - 7
CT06A-01 9 6A 9 - 2
CT06A-03 14 6A 13 5 2 3 5
6B 1 5 2 3 5 Serotype 6B according to Quellung
reaction
CT06A-04 2 6A 2 2 1 1 -
CT06B-01 41 6B 34 - 2
6A 7 - 3 Serotype 6A according to Quellung
reaction
CT06B-02 2 6B 2 27 17 10 29 BLAST: perfect match with serotype 6B
(AF246897)
7
CT06C-01 6 6C 6 - ND Serotype 6C according to PCR
CT07F-01 139 7F 139 - -
CT08-01 72 8 72 - -
CT08-02 1 8 1 1 1 1
CT08-03 1 8 1 2 2 2
CT08-05 1 8 1 1 1 1
CT09N-01 20 9N 20 - -
CT09V-01 86 9V 86 - 1
CT09V-02 1 9V 1 1 1 2
CT10A-01 17 10A 17 - -
CT10A-02 1 10A 1 1 1 1
CT11A-01 15 11A 15 - -
CT12F-01 18 12F 18 - 10
CT12F-02 1 12F 1 2 1 1 8
CT14-01 95 14 95 - -
CT14-02 80 14 80 1 1 1
CT15A-01 3 15A 3 - -
CT15B-01 8 15B 8 - 62
CT15C-01 2 15C 1 - 10
17F 1 - 1 Serotype 17F according to Quellung
reaction, 1 mm with CT17F-01
CT15F-01 1 15B 1 - 11 BLAST:perfect match with serotype 15F
(CR931666),64 mm with CT15B-01
CT16F-01 12 16F 12 - -
CT16F-02 1 16F 1 1 1 1
CT17F-01 6 17F 6 - -
CT18A-01 1 18A 1 - -
CT18C-01 26 18C 24 - -
18B 2 - - 18B and 18C are indistinghuisable
according to Bentley et al.
CT18C-02 1 18C 1 14 12 2 14 BLAST: best match (97% identity) with
several serotypes
CT18C-03 1 18C 1 1 1 1
CT18F-01 1 18C 1 BLAST: best match (97% identity) with
several serotypes
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isolates in which one or more of the BOX loci could not be
amplified. In 20 (29%) of the 68 serotype 23F (CT23F-01) isolates
BOX_11 locus could not be amplified, which contributed another
6% to all isolates with an allele 99.
For the BOX_02 locus there were 82 isolates that yielded a
PCR fragment of unusual size. Sequence analysis revealed a
number of deletions in the region flanking the BoxB repeats in this
BOX locus. In these cases the locus was assigned the number of
BoxB repeats, irrespective of the mutations in the flanking regions.
Remarkably, 66 (83%) of the isolates with CT14-02 had a
mutation in the flanking regions. Also 10 isolates carrying a
deletion in the flanking regions were CT06B-01, making up 25%
of this CT in the collection. The BOX_02 locus was the only locus
in which alleles with aberrant sizes were found.
Snapshot of the pneumococcal population in the
pre-vaccination era
In Figure 2, a minimum spanning tree displays the 444 MLVA
types that were obtained by MLVA of the 1154 isolates. In
general, there was a strong correlation between MLVA type and
serotype. However, several serotypes were distributed over various
MLVA complexes. An example is serotype 14 which is divided
into 2 distinct MLVA complexes. For some serotypes, e.g. 19F, the
MLVA profiles were highly diverse. To illustrate the serotype
dependent variation in MLVA the minimum spanning tree based
on the MLVA of serotypes 7F, 14, 19A and 19F are depicted in
Figure 3. Of the 139 serotype 7F isolates 108 (78%) had an
identical MLVA profile and 136 (97%) isolates belonged to a
single MLVA complex. Serotype 14 isolates clustered in 2 large
complexes. Remarkably, the CST also yielded 2 CTs (CT14-01
CST Freq
1 Serotype Freq
2 Mut.Major
3 ds
4 dn
5 Mut.Bentley
6 Discrepancies and other remarks
CT19A-01 42 19A 42 - -
CT19F-01 24 19F 24 - -
CT19F-02 10 19F 10 1 1 1
CT19F-03 1 19F 1 1 1 1
CT19F-04 1 19F 1 4 3 1 4
CT20-01 7 20 7 - -
CT21-02 1 21 1 - -
CT22A-01 3 22A 3 - -
CT22F-01 23 22F 23 - -
CT23A-01 9 23A 8 - -
23F 1 - Autoagglutinable
CT23B-01 2 23B 2 - -
CT23F-01 68 23F 67 - -
15C 1 - 36 Autoagglutinable
CT23F-02 1 23F 1 1 1 1
CT23F-03 1 23F 1 1 1 1
CT23F-04 1 23F 1 31 21 10 31 BLAST: Best match (99% identity) with
several serotypes
CT24F-01 7 24F 6 - 33
40 1 - 80 Serotype 40 according to Quellung
reaction
CT25F-02 6 25F 4 - 1
38 2 - 1 25F and 38 are indistinghuisable
according to Bentley et al.
CT28A-01 1 28A 1 - -
CT29-01 2 29 2 - 1
CT31-01 3 31 3 - -
CT33F-01 6 33F 6 - 9
CT33F-02 7 33F 7 - -
CT34-01 2 34 2 - -
CT35F-01 4 35F 4 - -
1Frequency of the CT.
2Frequency of the serotype.
3Number of mutations with the major CT of the particular serotype.
4Silent mutation.
5Non-silent mutation.
6Number of mutations with the wzh gene segment published by Bentley et al. [21].
7Also perfect match with wzh sequences of 6B isolates AY359459, AY359455, AY359449.
doi:10.1371/journal.pone.0020390.t001
Table 1. Cont.
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agreement with separation into 2 complexes obtained by MLVA.
The distribution of the serotype 7F and 14 isolates over the MVLA
complexes was similar irrespective of the age of the patients from
which the strains were isolated. In contrast, more diversity was
observed within the serotype 19A and 19F isolates. The MLVA of
serotype 19F yielded many different MLVA types that were
distributed over various complexes. Among the 36 serotype 19F
isolates there were 35 different MLVA types. As a result virtually
each isolate had its own MLVA type leading to a very high degree
of diversity with a DI of 99.5%. However, the majority of the
isolates belonging to CT19F-01 were closely related based on
MLVA. Also, BOX_4 was absent in 12 of the 36 serotype 19F
isolates. The collection contained 75 serotype 8 and 15 serotype
11A isolates. Although 21 different MLVA types were found,
serotypes 8 and 11A were indistinguishable by MLVA. Inspection
of the MLST profiles of serotypes 8 and 11A in the S. pneumoniae
database (www.mlst.net) showed that the profiles of serotypes 8
and 11A are related but distinct. To verify this for our isolates, we
performed MLST on 4 serotype 8 isolates and 4 serotype 11A
isolates and this resulted also in related but distinct profiles.
MLVA of serogroup 6 isolates
The serogroup 6 isolates possessed unusual characteristics both
in CST and MLVA. Serogroup 6 yielded 3 serosubtypes, 6 distinct
CTs and 53 MLVA types. Seven of the serotype 6A isolates had
CT06B-01, a capsular sequence type that was also found in 34
serotype 6B isolates. In addition, there was a single serotype 6B
isolate that carried a wzh gene sequence identical to that of 13
serotype 6A isolates (CT06A-03). The picture became even more
complex when the MLVA data were used to construct a minimum
spanning tree (Figure 4). With the exception of a single isolate all
CT06A-01 isolates clustered in a single MLVA complex. The
CT06A-03 isolates and the CT06C-01 isolates appeared to be
closely related. The 6B isolates (CT06B-01) clustered in 3 MLVA
complexes. The serotype 6A isolates that carried a wzh sequence
that was indistinguishable from that of a subpopulation of serotype
6B isolates (CT06B-01) clustered as a separate MLVA complex
which differed completely from all other serotype 6A and 6B
isolates.
Discussion
The aim of this study was to create a genotypic snapshot of the
Dutch pneumococcal population in the pre-vaccination era of
isolates isolated from patients with invasive disease. A newly
designed molecular typing technique named Capsular Sequence
Typing (CST) was used to assess the serotype. Isolates were also
genotyped with MLVA to determine the genetic background from
1154 pneumococcal isolates.
Clustering of the MLVA profiles strongly correlated with
serotype and CST distribution. The serotype 7F isolates had a
diversity index of only 40% based on the MLVA profiles,
indicating that the genetic background of this serotype is well
conserved. Analysis of the MLST data of pneumococcal isolates
from the UK present in the international publicly accessible
MLST database (www.mlst.net) showed that serotype 7F isolates
were highly clonal. The homogenous background of this serotype
could suggest a rapid expansion or that this serotype evolves
slowly. Serotype 14 was divided into 2 major MLVA types in our
collection, and also in 2 major MLST types according to the UK
data in the MLST database. For some serotypes there were many
different MLVA profiles that often differed considerably in
composition, reflecting a very heterogeneous genetic background.
This was most pronounced for serotype 19F that yielded the
highest diversity (DI=99,5%) in the MLVA. Such result may
suggest the 19F capsular gene cluster is transferred horizontally
quite frequently among pneumococci with various genetic
backgrounds. Although recombination of the capsular biosynthetic
Table 3. Serotype distribution of pneumococci causing
invasive diesease in patients in the age categories ,5 and $5
year.
,5y r $5y r
Serotypes n (%) n (%)
14 26 (26) 149 (14)
7F 10 (10) 129 (12)
44 ( 4 ) 8 2 ( 8 )
9V 6 (6) 80 (8)
13 ( 3 ) 7 9 ( 8 )
82 ( 2 ) 7 3 ( 7 )
23F 6 (6) 65 (6)
32 ( 2 ) 5 9 ( 6 )
19A 7 (7) 35 (3)
19F 5 (5) 31 (3)
6B 12 (12) 25 (2)
18C 5 (5) 22 (2)
Other 12 (12) 225 (21)
Total 100 1054
doi:10.1371/journal.pone.0020390.t003
Table 2. Characteristics of the patients that were infected
with the isolates included in the snapshot.
Blood CSF Total
Age of patients
0 – 1 y r 3 02 25 2
1 – 4 y r 3 51 34 8
5 – 9 y r 921 1
10–14 yr 7 0 7
15–19 yr 10 1 11
20–29 yr 21 2 23
30–39 yr 56 3 59
40–49 yr 72 6 78
50–64 yr 203 35 238
65–79 yr 391 32 423
80+ yr 200 4 204
Gender of patients
Female 472 60 532
Male 541 59 600
Unknown 21 1 22
Isolation year
2004 492 69 561
2005 542 51 593
Total 1034 120 1154
doi:10.1371/journal.pone.0020390.t002
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horizontal transfer of a particular capsular gene clusters has not
been reported. Also MLST revealed that serotype 19F isolates are
highly diverse in the composition of the housekeeping genes. The
publicly accessible MLST data do not represent the true
distribution of STs in the UK and as such cannot be used to
draw firm conclusions. However, the trend is obvious. Jefferies
et al. created a snapshot for Scottish isolates genotyped by MLST
[24]. Their analysis also resulted in highly clonal serotype 7F
isolates and genetically diverse serotype 19F isolates. The number
of isolates per serotype in their snapshot was only 15 isolates or less
making comparison with our MLVA data somewhat inaccurate.
However, from their study and from studies performed by others
[25,26,27] it is clear that both MLST and MLVA yield type
distribution that is strongly associated with serotypes. In the
companion paper we compare the MLVA with MLST and PFGE
on 263 isolates. Results of this study showed a very good
congruence between MLST and MLVA.
CST is a molecular method to assess the serotype based on the
wzh gene of the capsular locus. This gene was chosen for
sequencing because it varies sufficiently between serotypes, but is
conserved enough to amplify the same gene segment of the various
serotypes using a single mix of primers. The wzh gene of the
capsular locus is a regulatory gene important for the initial
phosphorylation in the capsule production [28]. Alterations in the
sequence of this gene may influence the level of capsule expression,
but it is unlikely that it will affect the composition of the capsular
polysaccharides. Further analysis of the level of expression of wzh
Figure 1. The frequency of the various alleles present in the 8 BOX loci used for MLVA. The graphs display the frequency of each allele
(number of repeats) for each BOX locus. The Simpson’s Diversity Index is indicated for each BOX locus. The number 99 was assigned if no PCR product
could be amplified.
doi:10.1371/journal.pone.0020390.g001
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expression. Such studies are important as increased expression of
the capsule may require higher concentrations of antibodies to
prevent pneumococcal disease. Vaccination may select for less
sensitive variants and may even eventually lead to vaccine escapes.
CST performed quite well and was able to confirm the serotype
identified by the Quellung reaction in most cases. However, in
some cases CST yielded ambiguous results where it did not match
serotyping despite repeated analysis. Two discrepancies could be
explained by an autoagglutinable character of those isolates.
However, in 4 cases the discrepancy remained unexplained,
additional typing based on other genes may be required to
distinguish these serotypes. In 2 of these cases, the isolates with
serotype 40 and 24F and isolates with serotype 18B and 18C, the
MLVA profiles of the isolates were similar. In the other cases, the
MLVA profiles were completely different. Evidently, the linkage
between wzh sequence and serotype is not fully restricted.
Horizontal transfer of complete capsular genes or parts thereof
could change the composition of the genes or gene clusters,
without changing the serotype. This may be particularly true for
regulatory genes such as the wzh gene which may be involved in
the level of production of the capsule, but do not determine the
composition of the capsular polysaccharide.
The genotypic characteristics of isolates in serogroup 6 were
remarkably diverse. Recent studies have shown that the serogroup
6 isolates are genetically diverse and two new serotype designated
6C and 6D have been identified [4]. However, from these studies
there are indications that serogroup 6 may contain even more
serotypes. Serotype 6B is associated with vaccine failure in the UK
[29] and also in the Netherlands (unpublished data). It is believed
that insufficient response to vaccination caused by the poor
immunogenic character of the 6B polysaccharides may be
responsible for the vaccine failures. However, the apparent
heterogeneity in CST and MLVA within serotype 6B may suggest
several other serotypes within serogroup 6. This may also play a
role in these vaccine failure cases. Our MLVA data is supported
by MLST of serotype 6A and 6C isolates that also showed
overlapping genotypes [30].
Figure 2. Minimum spanning tree of the results obtained by MLVA of 1154 pneumococcal isolates. The minimum spanning tree is based
on the entire MLVA database (last accessed on October 20, 2010) with only the results from the current collection plotted within. The circles indicate
the types and the size of the circles indicate the number of isolates. Lines linking two types denote a single locus difference between those types. The
colors of the circles indicate the serotype of the isolates and complexes were indicated by grey halos.
doi:10.1371/journal.pone.0020390.g002
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the serotype and used this method together with MLVA to create
a snapshot of the composition of the Dutch pneumococcal
population causing invasive disease in the pre-vaccination era.
The use of both methods provides insights in the genetic
background of the pneumococcus and the serotype specific
capsular genes and can be used to observe changes in the
pneumococcal population, including serotype replacement and
capsule switch. Comparison with a snapshot made from the
pneumococcal population after the introduction of the conjugate
vaccine in the Netherlands may reveal such changes.
Materials and Methods
Isolates
Pneumococcal isolates were isolated from blood or CSF from
patients with invasive pneumococcal disease and collected by the
Netherlands National Reference Laboratory for Bacterial Menin-
gitis (NRBM) in Amsterdam. The 1154 isolates used for the
snapshot were isolated by 9 large Medical Microbiology
laboratories referred to as the sentinel laboratories and represented
approximately 25% of all cases from Dutch patients with invasive
pneumococcal disease in the Netherlands in 2004 and 2005. In
Table 2 the characteristics of the patients that were infected with
the isolates used for the snapshot are shown. Serotyping was done
at the Reference Laboratory using the Quellung reaction as
previously described [13,14]. For molecular analyses bacteria were
grown in 1 ml Brain Heart Infusion Broth with 0.5% yeast-extract
overnight at 37uC and 5% CO2. Of each culture 500 ml was
heated for 10 min at 95uC and these lysates were either used
directly or stored at 220uC until use.
The ethical committees (METC) of the University Medical
Center Utrecht approved this study and waived the requirement
for informed consent (METC Utrecht protocol number: 07-289/
C), since cultures were obtained as part of the national surveillance
program.
Figure 3. Minimum spanning trees of the results obtained by MLVA of 4 major serotypes. The minimum spanning tree is based on the
entire MLVA database and the results of the pre-vaccination era collection (n=1154) were plotted within in white nodes. The colored nodes
designate the isolates of the 4 major serotypes described in the text. The colors of the nodes indicate the Capsular Type. For symbols and lines see
Figure 2.
doi:10.1371/journal.pone.0020390.g003
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CST primers targeting the wzh gene were designed based on
the capsular biosynthesis gene sequences determined by Bentley
et al. [21]. To be able to amplify the wzh genes of all
pneumococcal serotypes in a single PCR, 3 forward and 4
reverse primers were designed a n du s e da sam i x t u r ei nt h eP C R
(Table 4). Primer design was done using Kodon 3.5 software
(Applied Maths, Sint-Martens-Latem, Belgium). The primers
were designed with 59-M13-tails to facilitate DNA sequencing
with a single M13 primer set. To amplify the partial wzh gene
25 ml PCR mixtures containing Hotstartaq mix (Qiagen,
Hilden, Germany), 10 mMo fe a c hp r i m e ra n d5ml 1:10 diluted
lysate were used. The PCR reaction was as follows: 15 min
95uC, 40 cycles of 20 sec 95uC, 30 sec 51uCa n d3 0s e c7 2 uC
followed by 7 min 72uC. PCR products were purified using
ExosapIt (GE Healthcare Life Sciences, Chalfont St Giles, U.K.)
according to manufacturer’s protocol. One mla l i q u o t so ft h e
purified PCR products were used in sequence reactions with
M13 forward and reverse primers using Big Dye Terminator
technology (Applied Biosystems, Foster City, U.S.A.) on an AB
3730 genetic analyzer.
All wzh variant sequences are made publicly available through
www.MLVA.net.
PCR for detection of serotype 6C
Detection of serotype 6C was performed with a specific PCR
using primers targeting the wciN gene (Table 4). The primers were
designed based on the publicly available sequence as established
by Park et al. [22]. To amplify the wciN gene, 25 ml PCR mixtures
contained Hotstartaq mix (Qiagen, Hilden, Germany), 10 mMo f
the forward primer and 10 mM of reverse primer and 5 ml 1:10
diluted lysate. The PCR reaction was as follows: 15 min 95uC, 40
cycles of 20 sec 95uC, 50 sec 46uC and 30 sec 72uC followed by
7 min 72uC. The yield of a PCR product was assessed by
electrophoresis on a 1% agarose gel and isolates were assigned
serotype 6C if PCR products were obtained. Based on the
available sequence of serotype 6D, this PCR would also yield a
PCR product on serotype 6D isolates [6].
Figure 4. Minimum spanning trees of the results obtained by MLVA for serogroup 6. The minimum spanning tree is based on the entire
MLVA database and the results of the pre-vaccination era collection (n=1154) were plotted within in white nodes. The colored nodes designate the
serogoup 6 isolates of this collection. The colors of the nodes indicate the Capsular Type and the serotype is indicated within the figure. For symbols
and lines see Figure 2.
doi:10.1371/journal.pone.0020390.g004
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MLVA was performed as described in detail by Elberse and
Nunes et al. (companion paper). Briefly, 8 VNTR loci were
amplified in 2 multiplex PCRs in which one of the primers of each
primer pair carried a distinct fluorescent label. The PCR products
were mixed with fluorescently labeled size standard and sized on
an automated sequencer. Assessment of the number of repeats in
each locus was done using the GeneMarker software (Softgenetics,
State College, Pennsylvania, USA). The resulting table with
numerical profiles was imported into Bionumerics (Applied Maths,
Sint-Martens-Latem, Belgium) for cluster analysis.
Data Analysis
Data analysis and clustering were performed using Bionumerics
version 6.1 (Applied Maths, Sint-Martens-Latem, Belgium). All
sequences of the CST were assembled, edited, trimmed and
assigned a CT. The CT is a composite assignment; the first part of
the assignment is based on the phenotype assessed by conventional
serotyping and the second part of the assignment is the consecutive
number of the capsular type belonging to the same serotype. As an
example, CT09V-01 designated the first variant in wzh sequence
of an isolate serotyped as 9V.
Tables with the MLVA profiles were imported from the
Genemarker software into Bionumerics and the profiles were
clustered using a categorical similarity coefficient and displayed in
a minimum spanning tree. In a minimum spanning tree circles
indicate the types. The size of the circle indicates the number of
isolates with that particular MLVA profile. The circles are linked
based on the number of loci that differ in the MLVA profile. The
lines linking 2 types in the tree denotes a single locus difference
between these types. For assignment of MLVA complexes, the
entire in-house MLVA database (available at www.mlva.net) was
interrogated (last accessed on October 20, 2010). MLVA complex
assignment was based on a maximum distance of one locus
between related types. The minimum number of MLVA types in a
MLVA complex was set to 3 with a minimum of 9 entries per
MLVA complex, resulting in on average 3 isolates within an
MLVA type. Complexes are depicted as halos surrounding the
types.
The genetic diversity in MLVA profiles of the isolates was
calculated with Simpson’s index of diversity [31,32,33].
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